Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
about
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiologyApproaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeTreatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS).Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy.Complement, thrombotic microangiopathy and disseminated intravascular coagulation.Recent advances in understanding enteric pathogenic Escherichia coli.Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regionsIdentification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membraneShiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury.Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primatesModulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract.Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10.Targeting bacterial toxins.Shiga Toxin Therapeutics: Beyond Neutralization.
P2860
Q27025422-A195542B-99E8-44B3-BBC3-C5355F72D013Q28087714-69AF1693-76C4-4689-9393-EB61ADEA257EQ33399468-525A536E-18F4-42BA-8149-81BA60AB4D5EQ33402784-8E6A11EB-6849-4984-9107-5AE5CE7A2CB1Q33404640-EB722117-EADB-4897-A192-1C6F65421F5BQ33405827-CE0A43D8-674B-4649-A414-1DAFC2F087A3Q33408183-0BD40496-658F-41EA-8776-6A731DED6DEBQ33420624-3442D56E-078D-43FF-BBBB-5CDF10FCD1FCQ34375210-135EF64D-BCD5-4EF3-BAEF-578ED99F60B5Q34643412-8D8F581F-95CA-4AA0-908A-9987FCDCA51BQ34933393-BA531751-2044-4787-BD1F-78F908D7EBABQ35003696-67D64EF9-1E0F-4860-8340-567738C5258DQ36068651-451BFCB0-3B95-4139-B2EB-AB394D5A2C60Q36510003-AB1007A4-48B0-4A9E-85EC-6E795EF0B2CEQ37009028-5CB3E3C6-FDFD-4B98-B2A6-727F64F43EBEQ37643869-041B2945-E244-455B-90B8-E04B73BCC72BQ37996325-C3C7C1D2-DDD4-4549-978D-5796C193D344Q41669177-1E5364BB-B59D-4FA5-AA90-A90036EF7393
P2860
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@ast
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@en
type
label
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@ast
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@en
prefLabel
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@ast
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@en
P2093
P2860
P1433
P1476
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
@en
P2093
Caitlin S Leibowitz
Diann Debord
Kiyotaka Nishikawa
Scott Freeman
Sun-Young Oh
Valta Collins
P2860
P2888
P304
P356
10.1007/S00467-011-1913-Y
P577
2011-05-21T00:00:00Z
P5875
P6179
1034794349